.png)
ProteusDx™ by FirstVitals® Business Summary
FirstVitals® is redefining the future of gastrointestinal diagnostics with a bold, AI-first approach to Video Capsule Endoscopy (VCE). We’re not just leading this emerging market, we’re expanding it.
As the first mover in AI-powered VCE across humans, companion pets, and large animals, FirstVitals® is unlocking a new frontier in multi-species diagnostics. Our proprietary platform seamlessly integrates wireless capsule endoscopy with real-time AI interpretation, enabling non-invasive, accurate, scalable GI imaging that revolutionizes early disease detection.
In human healthcare, our AI-enhanced platform improves accuracy, reduces bottlenecks, and expands access to care, particularly in rural and underserved areas. We go further with our patented veterinary solution, bringing the same advanced technology to dogs, cats, and elite performance horses-meeting a high-margin, urgent diagnostic need in markets with little direct competition.
Investors have a rare window to join this paradigm shift. With a platform bridging human and veterinary medicine, a rapidly expanding TAM, and proprietary IP across AI and capsule technology, FirstVitals® is positioned to lead a new category in precision diagnostics.
The race to lead AI in GI imaging has already begun. Will you join the company shaping the future, or watch from the sidelines?
Human Health
The human GI market faces persistent bottlenecks: limited specialist availability, delays in endoscopy scheduling, and high procedural costs. ProteusDx™ is transforming GI care with an FDA-cleared capsule platform enhanced by AI, delivering accurate detection of GERD, ulcers, and other GI conditions, without the need for sedation or scoping.
But we’re not stopping at diagnostics. By enabling earlier treatment, better outcomes, and lower costs, ProteusDx™ supports the shift toward outpatient and remote care models. As healthcare moves to meet rising demand for scalable, patient-friendly solutions, ProteusDx™ empowers clinics and health systems to deliver fast, non-invasive GI care anywhere.
Companion Pets
Diagnosing GI conditions in pets is challenging. Traditional endoscopy is invasive, costly, and often unavailable, leaving many cases undiagnosed or delayed. ProteusDx™ changes this with a smart, capsule-based platform designed specifically for dogs and cats, with the ability to scan the entire GI track, detecting ulcers, IBD, tumors, and motility disorders through AI-powered image analysis.
With no need for sedation or specialty referrals, ProteusDx™ empowers veterinarians to deliver faster, accurate diagnostics directly in practice. This high-margin, consumer-pay market is ripe for disruption, with pet owners willing to invest in advanced care and no direct competitors offering smart capsule diagnostics at scale.
Equine
Up to 90% of performance horses suffer from gastric ulcers, yet traditional diagnosis is invasive, costly, and often inaccessible. ProteusDx™ Equine offers a safe, swallowable capsule platform that detects ulcers, delivers targeted therapy, and monitors healing conveniently, without sedation or scoping.
This enables trainers, breeders, and owners to optimize performance and wellness proactively, supporting the health and careers of elite equine athletes. Serving a high-value, self-pay market with rapid adoption cycles, ProteusDx™ Equine is positioned to redefine standards of care in equine GI health.
The human gastrointestinal market faces bottlenecks: limited specialists, delayed endoscopies, and costly procedures. ProteusDx™ transforms GI diagnostics with an FDA-cleared capsule platform enhanced by AI, offering accurate detection of GERD, ulcers, and other GI conditions without sedation or scoping.
We're not just improving diagnostics-we’re enabling earlier treatment, better outcomes, and reduced costs. As healthcare shifts toward outpatient and remote models, ProteusDx™ empowers clinics and health systems to meet rising demand for fast, scalable solutions.
Veterinarians face challenges diagnosing GI issues in pets-traditional endoscopy is invasive, expensive, and often unavailable. ProteusDx™ provides a non-invasive, capsule-based solution tailored for dogs and cats, detecting ulcers, IBD, tumors, and motility issues with AI-driven image analysis.
This consumer-pay segment is ripe for disruption, with high spending tolerance among pet owners and virtually no direct competitors offering smart capsule diagnostics.
Up to 90% of performance horses suffer from gastric ulcers-yet traditional diagnosis is difficult, often skipped, and requires sedation and scoping. ProteusDx™ Equine introduces a safe, ingestible solution that detects ulcers, delivers localized treatment, and monitors healing-all without invasive procedures.
This gives trainers, breeders, and owners a revolutionary tool to optimize performance and wellness, all in a high-value, self-pay market with fast adoption cycles.
Why Invest in FirstVitals®?
Non-invasive, AI-powered Video Capsule Endoscopy (VCE) for human and veterinary markets, with limited or no direct competitors in a rapidly growing field.
SaaS + licensing strategy enables recurring revenue streams across both clinical and veterinary channels.
FDA-cleared VCE platform with AI integration underway, positioning FirstVitals® for accelerated market entry.
Targeting a $1.5B+ human endoscopy market and an untapped, high-margin veterinary GI market, with significant global expansion potential.
Validated demand from hospitals, healthcare providers, and veterinary networks seeking faster, scalable GI diagnostics.
Terms of the Offering
The minimum commitment for investors is 100 shares, priced at $8.50 per share, resulting in an initial investment of $850.
Product Development
Sales and Marketing
Operations and Infrastructure
Regulatory
Compliance and Legal
General and Administrative
Working Capital
Organization and
Offering Expenses
Leadership Team
Why using Biotech
Lorem ipsum dolor sit amet consectetur quam risus adipiscing sodales sed diam maecenas volutpat purus at consequat.
Increase your productivity
Lorem ipsum dolor sit amet consectetur quam risus adipiscing sodales sed diam maecenas volutpat purus at consequat.
Get the best sleep ever
Volutpat ac sit aliquet ipsum viverra id magna egestas sit lacus volutpat interdum aliquet dui nibh scelerisque est felis nullam augue tincidunt sagittis.
Reach your fitness goals
Vitae sed fringilla dignissim interdum nibh commodo mauris egestas volutpat risus pellentesque ut cursus viverra duis scelerisque ac orci a elit mauris.
Connect all your devices
Lorem ipsum dolor sit amet consectetur quis euismod aenean laoreet varius ac non aenean accumsan fringilla vitae.
What our users say
Lorem ipsum dolor sit amet consectetur nunc dictumst viverra metus enim nec pellentesque rhoncus duis purus nibh sagittis nibh morbi vitae ac.
John Carter
Manhattan, NY
“A game-changer for health monitoring. It's intuitive and incredibly precise”
Urna aliquet sit morbi luctus amet dolor suspendisse mauris fames dignissim est turpis eu purus tellus ipsum quis turpis.
Sophie Moore
San Diego, CA
“A game-changer for health monitoring. It's intuitive and incredibly precise”
Urna aliquet sit morbi luctus amet dolor suspendisse mauris fames dignissim est turpis eu purus tellus ipsum quis turpis.
Matt Cannon
New York, NY
“A game-changer for health monitoring. It's intuitive and incredibly precise”
Urna aliquet sit morbi luctus amet dolor suspendisse mauris fames dignissim est turpis eu purus tellus ipsum quis turpis.
Andy Smith
San Francisco, CA
“A game-changer for health monitoring. It's intuitive and incredibly precise”
Urna aliquet sit morbi luctus amet dolor suspendisse mauris fames dignissim est turpis eu purus tellus ipsum quis turpis.
Blog & resources
Lorem ipsum dolor sit amet consectetur quam risus adipiscing sodales sed diam maecenas volutpat purus at consequat.
ProteusDx™ by FirstVitals® is redefining diagnostics with AI-enhanced capsule endoscopy. Be part of the next wave in healthcare innovation.
FirstVitals Inc
2605 Camino Tassajara #2500, Danville, CA 94526
Questions? invest@firstvitals.com